BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 32822738)

  • 21. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines.
    Fujigaki H; Saito K; Fujigaki S; Takemura M; Sudo K; Ishiguro H; Seishima M
    J Biochem; 2006 Apr; 139(4):655-62. PubMed ID: 16672265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1.
    Moretti S; Menicali E; Nucci N; Voce P; Colella R; Melillo RM; Liotti F; Morelli S; Fallarino F; Macchiarulo A; Santoro M; Avenia N; Puxeddu E
    J Biol Chem; 2017 Feb; 292(5):1785-1797. PubMed ID: 27994058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
    Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
    Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic analogue of S-benzylisothiourea that suppresses kynurenine production without inhibiting indoleamine 2,3-dioxygenase activity.
    Fukuda M; Sasaki T; Hashimoto T; Miyachi H; Waki M; Asai A; Takikawa O; Ohno O; Matsuno K
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2846-2849. PubMed ID: 30055888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers.
    Noonepalle SK; Gu F; Lee EJ; Choi JH; Han Q; Kim J; Ouzounova M; Shull AY; Pei L; Hsu PY; Kolhe R; Shi F; Choi J; Chiou K; Huang TH; Korkaya H; Deng L; Xin HB; Huang S; Thangaraju M; Sreekumar A; Ambs S; Tang SC; Munn DH; Shi H
    Cancer Immunol Res; 2017 Apr; 5(4):330-344. PubMed ID: 28264810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
    Yu J; Wang Y; Yan F; Zhang P; Li H; Zhao H; Yan C; Yan F; Ren X
    J Immunol; 2014 Sep; 193(5):2574-86. PubMed ID: 25063873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SAHA down-regulates the expression of indoleamine 2,3-dioxygenase via inhibition of the JAK/STAT1 signaling pathway in gallbladder carcinoma cells.
    Zhang P; Jiang G; Gao J; Li L; Du J; Jiao X
    Oncol Rep; 2013 Jan; 29(1):269-75. PubMed ID: 23042548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.
    Li W; Katz BP; Spinola SM
    Infect Immun; 2011 Aug; 79(8):3338-47. PubMed ID: 21576329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels.
    Jiang GM; He YW; Fang R; Zhang G; Zeng J; Yi YM; Zhang S; Bu XZ; Cai SH; Du J
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1840-6. PubMed ID: 20691806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.
    Jeong YI; Kim SW; Jung ID; Lee JS; Chang JH; Lee CM; Chun SH; Yoon MS; Kim GT; Ryu SW; Kim JS; Shin YK; Lee WS; Shin HK; Lee JD; Park YM
    J Biol Chem; 2009 Feb; 284(6):3700-8. PubMed ID: 19075017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
    Li Q; Harden JL; Anderson CD; Egilmez NK
    J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
    Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
    Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
    Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.
    Klar R; Michel S; Schell M; Hinterwimmer L; Zippelius A; Jaschinski F
    Cancer Immunol Immunother; 2020 Jan; 69(1):57-67. PubMed ID: 31802183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
    Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
    Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H
    Yang D; Li T; Li Y; Zhang S; Li W; Liang H; Xing Z; Du L; He J; Kuang C; Yang Q
    J Exp Clin Cancer Res; 2019 Feb; 38(1):88. PubMed ID: 30777103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of gamma interferon receptor expression due to Chlamydia-toll-like receptor interaction does not enhance signal transducer and activator of transcription 1 signaling.
    Shirey KA; Jung JY; Carlin JM
    Infect Immun; 2006 Dec; 74(12):6877-84. PubMed ID: 17030574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.